Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro

Protegrin-2, a potential inhibitor for targeting SARS-CoV-2 main protease Mpro

Background: SARS-CoV-2 variants continue to spread throughout the world and cause waves of COVID-19 infections. It is important to find effective antiviral drugs to combat SARS-CoV-2 and its variants. The main protease (Mpro) of SARS-CoV-2 is a promising therapeutic target due to its crucial role in...

Full description

Bibliographic Details
Main Authors:	Zainab Jan, Anupriya M. Geethakumari, Kabir H. Biswas, Puthen Veettil Jithesh
Format:	Article
Language:	English
Published:	Elsevier 2023-01-01
Series:	Computational and Structural Biotechnology Journal
Subjects:	Mpro COVID-19 SARS-CoV-2, antimicrobial peptides BRET assay Protegrin-2
Online Access:	http://www.sciencedirect.com/science/article/pii/S200103702300257X

Similar Items

Design of Protegrin-1 Analogs with Improved Antibacterial Selectivity
by: Ilia A. Bolosov, et al.
Published: (2023-07-01)

Dimerization of Protegrin-1 in Different Environments
by: Yiannis N. Kaznessis, et al.
Published: (2010-09-01)

In Silico Study of Secondary Metabolites in Dendrobium spp. as SARS-CoV-2 Antivirus on Main Protease (Mpro)
by: Anggiresti Kinasih, et al.
Published: (2022-03-01)

Protective Effects of Protegrin in Dextran Sodium Sulfate-Induced Murine Colitis
by: Evanna Huynh, et al.
Published: (2019-02-01)

Efficient Production of Recombinant Protegrin-1 From Pichia pastoris, and Its Antimicrobial and in vitro Cell Migration Activity
by: Evanna Huynh, et al.
Published: (2018-09-01)

THE POTENTIAL OF CARRAGEENAN FOR THE DRUG DISCOVERY OF COVID-19 VIA MOLECULAR DOCKING WITH ANGIOTENSIN-CONVERTING ENZYME 2 (ACE2) AND THE MAIN PROTEASE (MPRO) OF SAR-COV-2
by: Thet, H.A.
Published: (2022-11-01)

Protegrin 1 Enhances Innate Cellular Defense via the Insulin-Like Growth Factor 1 Receptor Pathway
by: Jenna Penney, et al.
Published: (2018-09-01)

In Silico Drug Repurposing of Penicillins to Target Main Protease Mpro of SARS-CoV-2
by: Baby Krishnaprasad, et al.
Published: (2020-11-01)

Effective Healing of <i>Staphylococcus aureus</i>-Infected Wounds in Pig Cathelicidin Protegrin-1-Overexpressing Transgenic Mice
by: Nagasundarapandian Soundrarajan, et al.
Published: (2023-07-01)

Coagulation modifiers targeting SARS-CoV-2 main protease Mpro for COVID-19 treatment: an in silico approach
by: Ísis Venturi Biembengut, et al.

Investigation of Thiocarbamates as Potential Inhibitors of the SARS-CoV-2 Mpro
by: Katarzyna Papaj, et al.
Published: (2021-11-01)

The importance of good practices and false hits for QSAR-driven virtual screening real application: a SARS-CoV-2 main protease (Mpro) case study
by: Mateus Sá Magalhães Serafim, et al.
Published: (2023-07-01)

Bat coronaviruses related to SARS-CoV-2: what about their 3CL proteases (MPro)?
by: Matteo Pavan, et al.
Published: (2022-12-01)

Finding potential inhibitors for Main protease (Mpro) of SARS-CoV-2 through virtual screening and MD simulation studies
by: N. Anis Ahamed, et al.
Published: (2023-12-01)

Protective and Anti-Inflammatory Effects of Protegrin-1 on <i>Citrobacter rodentium</i> Intestinal Infection in Mice
by: Celina Osakowicz, et al.
Published: (2021-08-01)

In silico exploration of Lycoris alkaloids as potential inhibitors of SARS-CoV-2 main protease (Mpro)
by: Fredrick Mutie Musila, et al.
Published: (2022-09-01)

Effect of dietary copper sources and concentrations on serum lysozyme concentration and protegrin-1 gene expression in weaning piglets
by: Jiayou Yan, et al.
Published: (2015-08-01)

Identification of SARS-CoV-2 Main Protease (Mpro) Cleavage Sites Using Two-Dimensional Electrophoresis and In Silico Cleavage Site Prediction
by: Noémi Miltner, et al.
Published: (2023-02-01)

Review on development of potential inhibitors of SARS-CoV-2 main protease (MPro)
by: Soumya Gulab Katre, et al.
Published: (2022-06-01)

Computational Simulation of HIV Protease Inhibitors to the Main Protease (Mpro) of SARS-CoV-2: Implications for COVID-19 Drugs Design
by: Wei Yu, et al.
Published: (2021-12-01)

Advances in the Development of SARS-CoV-2 Mpro Inhibitors
by: Laura Agost-Beltrán, et al.
Published: (2022-04-01)

Carvacrol, a Plant Metabolite Targeting Viral Protease (Mpro) and ACE2 in Host Cells Can Be a Possible Candidate for COVID-19
by: Hayate Javed, et al.
Published: (2021-02-01)

Structure-Dependent Immune Modulatory Activity of Protegrin-1 Analogs
by: Susu M. Zughaier, et al.
Published: (2014-11-01)

Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid
by: Jonathan T. Lee, et al.
Published: (2022-08-01)

Inhibition of SARS-CoV-2 Mpro with Vitamin C, L-Arginine and a Vitamin C/L-Arginine Combination
by: Ivana Đukić, et al.
Published: (2023-01-01)

Effect of chitooligosaccharide on the inhibition of SARS-CoV-2 main protease
by: Qian Wang, et al.
Published: (2023-02-01)

Protegrin-1 Regulates Porcine Granulosa Cell Proliferation via the EGFR-ERK1/2/p38 Signaling Pathway in vitro
by: Bo Pan, et al.
Published: (2021-05-01)

Towards potential inhibitors of COVID-19 main protease Mpro by virtual screening and molecular docking study
by: Moujane Soumia, et al.
Published: (2020-01-01)

Hemi-Babim and Fenoterol as Potential Inhibitors of MPro and Papain-like Protease against SARS-CoV-2: An In-Silico Study
by: Ahmad Alzamami, et al.
Published: (2022-04-01)

Structural and Biochemical Analysis of the Dual Inhibition of MG-132 against SARS-CoV-2 Main Protease (Mpro/3CLpro) and Human Cathepsin-L
by: Elisa Costanzi, et al.
Published: (2021-10-01)

Resistance to nirmatrelvir due to mutations in the Mpro in the subvariants of SARS-CoV-2 Omicron: Another concern?
by: Srijan Chatterjee, et al.
Published: (2023-06-01)

Comprehensive fitness landscape of SARS-CoV-2 Mpro reveals insights into viral resistance mechanisms
by: Julia M Flynn, et al.
Published: (2022-06-01)

Docking and Dynamics Study of Phytochemicals as Potent Inhibitors against SARS-CoV-2 Main Protease
by: Palla Ramprasad, et al.
Published: (2022-12-01)

Natural Compounds Activities against SARS-CoV-2 Mpro through Bioinformatics Approaches for Development of Antivirus Candidates
by: Taufik Muhammad Fakih
Published: (2021-07-01)

Unbinding ligands from SARS-CoV-2 Mpro via umbrella sampling simulations
by: Nguyen Minh Tam, et al.
Published: (2022-01-01)

Discovery and evaluation of active compounds from Xuanfei Baidu formula against COVID-19 via SARS-CoV-2 Mpro
by: Min Zhang, et al.
Published: (2023-08-01)

Myricetin Inhibits SARS-CoV-2 Viral Replication by Targeting Mpro and Ameliorates Pulmonary Inflammation
by: Ting Xiao, et al.
Published: (2021-06-01)

Computational Screening of Repurposed Drugs Targeting Sars-Cov-2 Main Protease By Molecular Docking
by: Yow Hui Yin, et al.
Published: (2022-09-01)

Natural phenolic compounds from Satureja L. as inhibitors of COVID-19 protease (Mpro): Computational investigations
by: Faika Başoğlu-Ünal, et al.
Published: (2022-01-01)

Allosteric Binding Sites of the SARS-CoV-2 Main Protease: Potential Targets for Broad-Spectrum Anti-Coronavirus Agents
by: Alzyoud L, et al.
Published: (2022-08-01)